Vorasidenib
- Generic Name
- Vorasidenib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H13ClF6N6
- CAS Number
- 1644545-52-7
- Unique Ingredient Identifier
- 789Q85GA8P
- Associated Conditions
- -
- Associated Therapies
- -
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
Phase 1
Not yet recruiting
- Conditions
- IDH2-mutant GliomaIDH1-mutant Glioma
- Interventions
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 45
- Registration Number
- NCT06478212
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
🇺🇸University of California Los Angeles, Los Angeles, California, United States
🇺🇸University of California, San Francisco (UCSF) School of Medicine, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath